How this Vancouver accelerator helps disruptive startups become unicorns

(Headway/Unsplash)

Victory Square Technologies (VST) is a venture capital accelerator based in Vancouver, Canada. On its website, one sentence summates its mission: “We offer early stage access to the next unicorns before they are unicorns.”

VST is publicly-traded, listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF). It matches tech startups with senior talent in product development, customer acquisition, engineering and more. These startups quickly scale towards monetization which in turn rewards shareholders.

According to a new research report, “the augmented reality (AR) market is projected to grow from USD 15.3 billion in 2020 to USD 77.0 billion by 2025. The report also says, “the virtual reality (VR) market is projected to grow from USD 6.1 billion in 2020 to USD 20.9 billion by 2025.”

Ambitious startups—the only caliber that VST recruits—will have access to numerous growth opportunities, including those in AR and VR. The Accelerator believes they’ll shape the 4th Industrial Revolution—dubbed as ‘Industry 4.0’—and become pillars of the future global economy.

VST’s current portfolio includes 20 high-impact companies focused on sectors that disrupt: digital health, machine learning, gaming, AI, VR, AR, cybersecurity, the internet of things, cryptocurrency and more.

A Test of Survival: COVID-19

In 2020, the pandemic was a survival test for startups of every type. Businesses of all sizes worked to operate at normal levels, but with fewer cash reserves. For startups without a backup plan, 2020 was a year of stagnation. COVID-19 was a catastrophe of such intensity that even corporations that survived the 2008 Global Financial Crisis found themselves unprepared.

Fortunately, the pandemic also served as a powerful catalyst for new technologies including AI, virtual communication, fintech and more. As a result, select startups flourished—and Victory Square Health was one of them.

Portfolio Company Takes World Stage with Rapid Covid-19 Test

With 20 years of diagnostics experience, Victory Square Health saw the pandemic as an opportunity to save lives. The VST subsidiary received FDA approval to sell its COVID-19 Rapid Antibody Tests in the US. The results are available in just five to 15 minutes and confirms whether a subject is positive for the contagious virus, has had it in the past or never at all.

Victory Square Health also received approval from the European Union to sell and distribute the test to its 446 million inhabitants. Brazilian ANVISA has also approved the company to sell the rapid test in the country of its origin—Brazil, of course.

With COVID-19 expected to remain a world issue for years to come, Victory Square Health will continue to attract investors with products of increased innovation. Its rapid tests have the potential for widespread distribution amongst government agencies, public spaces, borderlines and even airports.   

Loyal Shareholders Celebrate VST’s Promising Q3 Results

VST’s Q3 results report a record net income of $8,890,748 and earnings per share of $0.12 for the three-month period ending September 30, 2020. CEO Shafin Diamond Tejani expressed his appreciation for the latest balance sheet.   

“I am very pleased with our Q3 results, we are well-funded, have a solid portfolio, a strong team and a robust pipeline of catalysts to continue this aggressive growth trajectory,” said Tejani.

“We are confident that this momentum will continue in 2021. We’d like to thank our loyal shareholders and look forward to the next phase of this exciting journey.”

VST has stated that it’s undervalued and is well aware of this shortcoming. All the same, the accelerator is optimistic.

FansUnite Disrupts Gaming Industry

While the pandemic forced many traditional bricks-and-mortar casinos to close their doors, VST subsidiary FansUnite experienced an influx of legal online gambling on its iGaming platform. As a result of the company’s accelerated growth, Mackie Research advised clients to consider buying FansUnite shares.

On January 11, FansUnite CEO Scott Burden announced the closing of an upsized and oversubscribed $13,388,120 private placement due to investor demand. “The successful closing of this upsized financing provides further validation that the global gambling market is seeing a resurgence in demand from investors,” said Burton.   

“Despite the headwinds caused by the global pandemic in 2020, we saw consumers adopt and embrace online betting for its ease of access and simplicity.”

FansUnite has a strong digital infrastructure that serves as the driver of its success in the iGaming industry. The company has descended upon the $150 USD billion online legal gambling market and is poised for further success. As it partners with aggregators, FansUnite is ready to expand its audience with a momentum that many tech startups can only dream of.



Share on facebook
Facebook

Leave a Reply